---
title: CMIC HOLDINGS Co., Ltd. vs Sacura GmbH
slug_a: cmicgroup
slug_b: sacura-cro
site: cro
review_signal_gate: closed
canonical_path: /compare/cmicgroup/sacura-cro
---

# CMIC HOLDINGS Co., Ltd. vs Sacura GmbH

Side-by-side profile data from each company listing on this directory.

## CMIC HOLDINGS Co., Ltd.

- Profile: [/companies/cmicgroup](/companies/cmicgroup)

CMIC HOLDINGS Co., Ltd. — CMIC HOLDINGS is a Japanese healthcare group whose Pharmaceutical Solutions cover consulting, non-clinical CRO, CRO, CDMO, SMO and CSO services. The group says it supports pharmaceutical companies across the value chain from non-clinical stages through post-marketing.

Services: 11. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Preclinical (General)
- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## Sacura GmbH

- Profile: [/companies/sacura-cro](/companies/sacura-cro)

Sacura GmbH — Sacura specializes in clinical trial management and regulatory support for biotech and pharma companies, with expertise in complex international studies and late-stage preclinical-to-market development planning.

Services: 8. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Clinical Operations
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Preclinical (IND-Enabling)
- Phase I
- Phase II
- Phase III

### Sourcing models

- Full-Service Outsourcing (FSO)